India’s ₹50 Crore Drug-Discovery Track: Balancing Investor Access and Scientific Merit
Sudha Chandrashekar, Swasti; Umesh Chawla, Swasti
22 Oct 2026
Opinion • Grassroots Voices • Policymakers Perspectives • Expert Analysis • Policy Briefs
An independent institution that connects research and public policy through clear, evidence-based communication, guided by an apolitical, non-partisan ethos.

Sudha Chandrashekar is the CEO of Swasti.
2 articles
Sudha Chandrashekar, Swasti; Umesh Chawla, Swasti
Sudha Chandrashekar, Health Systems Transformation Platform (HSTP); Shambhavi Nimisha Prasad, Kempegowda Institute of Medical Sciences (KIMS); Ramesh Masthi N R, Kempegowda Institute of Medical Sciences (KIMS) ...